Clinical TrialsSearch results
Number of results: 482
Other
- Phase 2 study of cisplatin and pemetrexed in previously treated patients with malignant pleural mesothelioma
- Malignant pleural mesothelioma
- Hyogo College of Medicine
- 2008-01-04
Other
- Teprenone for preventing aggravation of COVID-19
- COVID-19
- ICHIHARA Eiki
- 2020-05-20
Other
- Randomized clinical study on diagnostic accuracy of magnified endoscopic examination with narrow band imaging (NBI) for small depressive lesion in the stomach
- Gastric cancer
- Innovation of New Diagnositic Modarities and Research on their diagnostic accuracy
- 2008-03-15
Other
- T-DXd vs. T-DM1 in high-risk HER2-positive patients with residual invasive breast cancer following neoadjuvant therapy
- HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer
- Inoguchi Akihiro
- 2020-12-01
Recruiting
- A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Breast Cancer
- Inoguchi Akihiro
- 2024-02-21
Recruiting
- A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
- Breast Cancer
- Inoguchi Akihiro
- 2023-01-22
Other
- A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer.
- Non-small cell lung cancer
- Institute of Biomedical Research and Innovation
- 2005-09-08
Recruiting
- A study of dostarlimab in combination with carboplatin-paclitaxel in Japanese participants with primary advanced or recurrent endometrial cancer
- Endometrial Cancer
- Ishibashi Hideyasu
- 2024-03-28
Other
- Effectiveness of zinc acetate hydrate supplementation in chronic kidney disease patients
- chronic kidney disease
- Itano Seiji
- 2021-08-27
Recruiting
- Efficacy and safety of NNC6019-0001 at two dose levels in participants with transthyretin amyloid cardiomyopathy (ATTR CM)(NN6019-4940)
- transthyretin amyloid cardiomyopathy (hATTR CM or wtATTR CM)
- Ito Junji
- 2023-06-21